| RS1600158346 |
GAMT
|
Health Risk |
Pathogenic |
Deficiency of guanidinoacetate methyltransferase, Cerebral creatine deficiency syndrome |
| RS1600158570 |
GAMT
|
Health Risk |
Pathogenic |
Cerebral creatine deficiency syndrome, Deficiency of guanidinoacetate methyltransferase |
| RS1600158650 |
GAMT
|
Health Risk |
Pathogenic/Likely pathogenic |
Cerebral creatine deficiency syndrome, Cerebral creatine deficiency syndrome |
| RS1600158894 |
GAMT
|
Health Risk |
Pathogenic |
Cerebral creatine deficiency syndrome, Deficiency of guanidinoacetate methyltransferase |
| RS1600159342 |
GAMT
|
Health Risk |
Likely pathogenic |
Deficiency of guanidinoacetate methyltransferase, Cerebral creatine deficiency syndrome |
| RS1600163739 |
SARS2
|
Health Risk |
Likely pathogenic |
SARS2-associated condition, SARS2-associated condition |
| RS1600167934 |
PPP2R1A
|
Health Risk |
Likely pathogenic |
Houge-Janssens syndrome 2, Houge-Janssens syndrome 2 |
| RS1600167941 |
PPP2R1A
|
Health Risk |
Likely pathogenic |
PPP2R1A-related disorder, Houge-Janssens syndrome 2 |
| RS1600169350 |
IDH3B
|
Health Risk |
Pathogenic |
Retinitis pigmentosa 46, Retinitis pigmentosa 46 |
| RS1600170070 |
BMP2
|
Health Risk |
Pathogenic |
Short stature, facial dysmorphism |
| RS1600173184 |
BMP2
|
Health Risk |
Pathogenic/Likely pathogenic |
Short stature, facial dysmorphism |
| RS1600173481 |
BMP2
|
Health Risk |
Likely pathogenic |
Short stature, facial dysmorphism |
| RS1600178720 |
JAG1
|
Health Risk |
Pathogenic |
Alagille syndrome due to a JAG1 point mutation, Alagille syndrome due to a JAG1 point mutation |
| RS1600178730 |
JAG1
|
Health Risk |
Pathogenic |
Alagille syndrome due to a JAG1 point mutation, Alagille syndrome due to a JAG1 point mutation |
| RS1600179237 |
JAG1
|
Health Risk |
Pathogenic |
— |
| RS1600179847 |
JAG1
|
Health Risk |
Pathogenic |
— |
| RS1600179855 |
JAG1
|
Health Risk |
Pathogenic |
Alagille syndrome due to a JAG1 point mutation, Alagille syndrome due to a JAG1 point mutation |
| RS1600179892 |
JAG1
|
Health Risk |
Pathogenic |
Alagille syndrome due to a JAG1 point mutation, Alagille syndrome due to a JAG1 point mutation |
| RS1600180395 |
CACNA1A
|
Health Risk |
Pathogenic |
— |
| RS1600180457 |
CACNA1A
|
Health Risk |
Pathogenic |
— |
| RS1600180659 |
CACNA1A
|
Health Risk |
Likely pathogenic |
Episodic ataxia type 2, Episodic ataxia type 2 |
| RS1600181733 |
JAG1
|
Health Risk |
Likely pathogenic |
Atypical coarctation of aorta, Atypical coarctation of aorta |
| RS1600182107 |
JAG1
|
Health Risk |
Pathogenic |
Alagille syndrome due to a JAG1 point mutation, Alagille syndrome due to a JAG1 point mutation |
| RS1600182812 |
JAG1
|
Health Risk |
Pathogenic |
Alagille syndrome due to a JAG1 point mutation, Alagille syndrome due to a JAG1 point mutation |
| RS1600184363 |
JAG1
|
Health Risk |
Likely pathogenic |
Atypical coarctation of aorta, Atypical coarctation of aorta |
| RS1600185499 |
JAG1
|
Health Risk |
Pathogenic |
Alagille syndrome due to a JAG1 point mutation, Cardiovascular phenotype |
| RS1600185804 |
JAG1
|
Health Risk |
Pathogenic |
— |
| RS1600186024 |
JAG1
|
Health Risk |
Pathogenic |
Alagille syndrome due to a JAG1 point mutation, Alagille syndrome due to a JAG1 point mutation |
| RS1600192503 |
DYM
|
Health Risk |
Pathogenic |
Dyggve-Melchior-Clausen syndrome, Dyggve-Melchior-Clausen syndrome |
| RS1600196349 |
JAG1
|
Health Risk |
Likely pathogenic |
— |
| RS1600196426 |
JAG1
|
Health Risk |
Likely pathogenic |
— |
| RS1600196443 |
JAG1
|
Health Risk |
Pathogenic |
Alagille syndrome due to a JAG1 point mutation, Alagille syndrome due to a JAG1 point mutation |
| RS1600196580 |
JAG1
|
Health Risk |
Pathogenic |
Alagille syndrome due to a JAG1 point mutation, Alagille syndrome due to a JAG1 point mutation |
| RS1600198365 |
CACNA1A
|
Health Risk |
Pathogenic |
Episodic ataxia type 2, Episodic ataxia type 2 |
| RS1600198481 |
CACNA1A
|
Health Risk |
Likely pathogenic |
Episodic ataxia type 2, Episodic ataxia type 2 |
| RS1600208852 |
SMARCA4
|
Health Risk |
Conflicting classifications of pathogenicity |
Rhabdoid tumor predisposition syndrome 2, Hereditary cancer-predisposing syndrome |
| RS1600242882 |
CACNA1A
|
Health Risk |
Pathogenic |
Episodic ataxia type 2, Episodic ataxia type 2 |
| RS1600244935 |
SEC23B
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital dyserythropoietic anemia, type II |
| RS1600271575 |
CACNA1A
|
Health Risk |
Pathogenic/Likely pathogenic |
Episodic ataxia type 2, Developmental and epileptic encephalopathy |
| RS1600272344 |
CACNA1A
|
Health Risk |
Pathogenic/Likely pathogenic |
Episodic ataxia type 2, Developmental and epileptic encephalopathy |
| RS1600273534 |
CACNA1A
|
Health Risk |
Pathogenic/Likely pathogenic |
Episodic ataxia type 2, Developmental and epileptic encephalopathy |
| RS1600274038 |
CACNA1A
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 42 |
| RS1600275237 |
TCF4
|
Health Risk |
Likely pathogenic |
Pitt-Hopkins syndrome, Pitt-Hopkins syndrome |
| RS1600277713 |
SMARCA4
|
Health Risk |
Likely pathogenic |
Rhabdoid tumor predisposition syndrome 2, Rhabdoid tumor predisposition syndrome 2 |
| RS1600278094 |
PLCB1
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 12 |
| RS1600278307 |
SMARCA4
|
Health Risk |
Conflicting classifications of pathogenicity |
Intellectual disability, autosomal dominant 16 |
| RS1600281886 |
SEC23B
|
Health Risk |
Pathogenic |
Congenital dyserythropoietic anemia, type II |
| RS1600285757 |
TCF4
|
Health Risk |
Pathogenic |
Pitt-Hopkins syndrome, Pitt-Hopkins syndrome |
| RS1600288964 |
SEC23B
|
Health Risk |
Likely pathogenic |
Congenital dyserythropoietic anemia, type II |
| RS1600290109 |
TCF4
|
Health Risk |
Pathogenic |
— |
| RS1600292507 |
CACNA1A
|
Health Risk |
Conflicting classifications of pathogenicity |
Developmental and epileptic encephalopathy, 42 |
| RS1600292598 |
CACNA1A
|
Health Risk |
Likely pathogenic |
Febrile seizure, Febrile seizure |
| RS1600293149 |
CACNA1A
|
Health Risk |
Pathogenic |
— |
| RS1600300837 |
SMARCA4
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, SMARCA4-related disorder |
| RS1600301361 |
SMARCA4
|
Health Risk |
Likely pathogenic |
Rhabdoid tumor predisposition syndrome 2, Rhabdoid tumor predisposition syndrome 2 |
| RS1600305570 |
NDUFAF5
|
Health Risk |
Likely pathogenic |
Mitochondrial complex I deficiency, nuclear type 16 |
| RS1600313212 |
CACNA1A
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 42 |
| RS1600324262 |
PRPF31
|
Health Risk |
Pathogenic |
Retinitis pigmentosa, Retinitis pigmentosa |
| RS1600324442 |
PRPF31
|
Health Risk |
Pathogenic |
Retinitis pigmentosa, Retinitis pigmentosa |
| RS1600328992 |
TBC1D20
|
Health Risk |
Likely pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS1600334904 |
PRPF31
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinitis pigmentosa, Retinitis pigmentosa |
| RS1600335148 |
PRPF31
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinitis pigmentosa, Retinal dystrophy |
| RS1600335289 |
PRPF31;PRPF31-AS1
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinitis pigmentosa, Retinitis pigmentosa 11 |
| RS1600335765 |
SMARCA4
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary cancer-predisposing syndrome, Rhabdoid tumor predisposition syndrome 2 |
| RS1600337143 |
PRPF31
|
Health Risk |
Pathogenic |
Retinitis pigmentosa 11, Retinitis pigmentosa 11 |
| RS1600337158 |
PRPF31
|
Health Risk |
Pathogenic |
Retinitis pigmentosa, Retinitis pigmentosa |
| RS1600340117 |
PRPF31
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinitis pigmentosa, Retinal dystrophy |
| RS1600341902 |
PRPF31
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa, Retinitis pigmentosa |
| RS1600341931 |
PRPF31
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa, Retinitis pigmentosa |
| RS1600342032 |
PRPF31
|
Health Risk |
Pathogenic |
Retinitis pigmentosa, Retinitis pigmentosa |
| RS1600342050 |
PRPF31
|
Health Risk |
Pathogenic |
Retinitis pigmentosa, Retinitis pigmentosa |
| RS1600344451 |
PRPF31
|
Health Risk |
Pathogenic |
Retinitis pigmentosa 11, Retinitis pigmentosa 11 |
| RS1600350656 |
PRPF31
|
Health Risk |
Pathogenic |
Retinitis pigmentosa, Retinitis pigmentosa |
| RS1600353301 |
CACNA1A
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 42 |
| RS1600355373 |
PRPF31
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa, Retinitis pigmentosa |
| RS1600355502 |
PRPF31
|
Health Risk |
Pathogenic |
Retinitis pigmentosa, Retinitis pigmentosa |
| RS1600356790 |
PRPF31
|
Health Risk |
Pathogenic |
Retinitis pigmentosa 11, Retinitis pigmentosa 11 |
| RS1600360338 |
PRPF31
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa, Retinitis pigmentosa |
| RS1600360654 |
PRPF31
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa, Retinitis pigmentosa |
| RS1600360827 |
PRPF31
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinitis pigmentosa, Retinitis pigmentosa |
| RS1600363764 |
CST3
|
Health Risk |
Conflicting classifications of pathogenicity |
CST3-related Leukodystrophy, Hereditary cerebral amyloid angiopathy |
| RS1600364712 |
SCN1B
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 52 |
| RS1600365455 |
SMARCA4
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1600370558 |
SCN1B
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 52 |
| RS1600388982 |
SMARCA4
|
Health Risk |
Conflicting classifications of pathogenicity |
Rhabdoid tumor predisposition syndrome 2, Intellectual disability |
| RS1600389034 |
SMARCA4
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Rhabdoid tumor predisposition syndrome 2 |
| RS1600392059 |
CSNK2A1
|
Health Risk |
Pathogenic |
Okur-Chung neurodevelopmental syndrome, Okur-Chung neurodevelopmental syndrome |
| RS1600393629 |
SMARCA4
|
Health Risk |
Conflicting classifications of pathogenicity |
Intellectual disability, autosomal dominant 16 |
| RS1600394125 |
SMARCA4
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Rhabdoid tumor predisposition syndrome 2 |
| RS1600394490 |
SAMHD1
|
Health Risk |
Likely pathogenic |
Multiple myeloma, Multiple myeloma |
| RS1600398069 |
SMARCA4
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Rhabdoid tumor predisposition syndrome 2 |
| RS1600404016 |
TCF4
|
Health Risk |
Pathogenic |
— |
| RS1600404795 |
TCF4
|
Health Risk |
Likely pathogenic |
Pitt-Hopkins syndrome, Corneal dystrophy |
| RS1600405252 |
SMARCA4
|
Health Risk |
Likely pathogenic |
Rhabdoid tumor predisposition syndrome 2, Hereditary cancer-predisposing syndrome |
| RS1600406856 |
TNFRSF11A
|
Health Risk |
Likely pathogenic |
— |
| RS1600407324 |
SMARCA4
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1600409143 |
THBD
|
Health Risk |
Likely pathogenic |
Abnormal bleeding, Thrombocytopenia |
| RS1600409323 |
THBD
|
Health Risk |
Likely pathogenic |
Abnormal bleeding, Thrombomodulin-related bleeding disorder |
| RS1600410451 |
THBD
|
Health Risk |
Conflicting classifications of pathogenicity |
Abnormal thrombosis, Atypical hemolytic-uremic syndrome with thrombomodulin anomaly |
| RS1600414549 |
PNKP
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 12 |